ArticleJournal of biochemical and molecular toxicology2026
4-FPAC-Modulated Tumor-Associated Macrophage Conditioned Media Suppresses Malignant Phenotypes and Promotes Cell-Cycle Arrest and Apoptosis in NSCLC.
Article in Journal of biochemical and molecular toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Non-small cell lung cancer (NSCLC) progression is strongly influenced by tumor-associated macrophages (TAMs), which frequently acquire an M2-like phenotype that promotes proliferation, epithelial-mesenchymal transition (EMT), angiogenesis, stemness, and therapy resistance. Previous studies from our group established the direct cytostatic and macrophage-polarizing effects of the synthetic coumarin derivative 4-fluorophenylacetamide-acetyl coumarin (4-FPAC), including ROS-mediated apoptosis, G0/G1 cell-cycle arrest, suppression of EMT-associated signaling in A549 cells, and promotion of M1-like macrophage polarization. In the present study, we investigated whether 4-FPAC-modulated TAM-derived conditioned media could suppress tumor-promoting behavior in A549 NSCLC cells. THP-1 monocytes were differentiated into macrophages and polarized using A549-conditioned medium to generate TAM-like macrophages. These TAMs were subsequently treated with 4-FPAC, and conditioned media from control or treated TAMs were applied to A549 cells to evaluate macrophage-associated anti-tumor effects. MTT analysis further showed that direct exposure of A549 cells to 4-FPAC under TAM-CM-supported conditions reduced cell viability in a dose-dependent manner. Functional assays demonstrated that conditioned media derived from 4-FPAC-treated TAMs significantly reduced A549 proliferation, inhibited migration and invasion, and impaired angiogenic responses in a chick chorioallantoic membrane model. Flow cytometry revealed G0/G1 cell-cycle arrest and reduced NANOG-positive stem-like cells, while DNA fragmentation and TUNEL assays confirmed enhanced apoptosis. Mechanistically, qRT-PCR and immunoblotting demonstrated EMT reversal, suppression of AKT signaling, VEGFα, IL8, OCT3/4, and NANOG, and upregulation of p21, p53, and caspase-3/cleaved caspase-3. Collectively, these findings demonstrate that 4-FPAC directly suppresses A549 viability under TAM-CM-supported conditions and modulates TAM-derived conditioned-media activity, highlighting its potential to target both tumor cells and tumor-macrophage interactions within the NSCLC microenvironment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.